FIELD: medicine, pharmaceutical industry. SUBSTANCE: invention relates to development of novel agents for rectal and vaginal using. Suppository comprises 46.0-47.8 wt.-% of liquid, purified, concentrated staphylococcus bacteriophage with lytic activity 1 x 10-7 as a biologically active agent and a hydrophilic base as a filling agent. Hydrophilic base can comprise gelatin, glycerol, carbonate-hydrocarbonate sodium buffer. EFFECT: enhanced biological activity of preparation. 2 cl
Title | Year | Author | Number |
---|---|---|---|
RECTAL AGENT | 1999 |
|
RU2152204C1 |
RECTAL MEANS FOR TREATING CHRONIC PROSTATITIS | 1999 |
|
RU2160114C1 |
RECTAL SUPPOSITORIES BASED ON MODIFIED BACTERIOPHAGE MS2 FOR TARGETED THERAPY OF MALIGNANT SOLID TUMOURS | 2019 |
|
RU2735828C1 |
PREPARATION FOR TREATMENT OF PATIENT WITH SUPPURATIVE-INFLAMMATORY DISEASES (VARIANTS) | 1997 |
|
RU2144368C1 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PROPHYLAXIS OF BACTERIAL INFECTION | 2012 |
|
RU2520346C2 |
BACTERIOPHAGE-CONTAINING PHARMACEUTICAL COMPOSITION AND METHOD FOR ITS PREPARING | 2002 |
|
RU2241446C2 |
IMMUNOBIOLOGICAL BACTERICIDAL PREPARATION (VERSIONS) | 2007 |
|
RU2366708C2 |
SEXTAPHAGE (PYOBACTERIOPHAGE POLYVALENT) OR BACTERIOPHAGE SALMONELLOUS PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING THEREOF | 2009 |
|
RU2410084C1 |
ANTIBACTERIAL COMPOSITION IN FORM OF SUPPOSITORY AND METHOD OF ITS PREPARATION | 2016 |
|
RU2622762C1 |
BACTERIOPHAGE COMPOSITION (VERSIONS) | 2007 |
|
RU2366437C2 |
Authors
Dates
2002-07-27—Published
2000-06-16—Filed